Peel L&P Environmental have reviewed the engineering work and have committed to the next stage of development and engineering the Protos Energy Park. Peel will now fund the next stage of development of the FMG® plant at Protos up to a financial close.
Plastic to hydrogen site planned for Ellesmere Port
With preliminary engineering for the site having been completed, the design now means DMG® facilities at Protos have the capacity to process 35 tonnes per day of waste plastics to produce up to two tonnes of hydrogen per day from the site.
In the next stage Peel will place contracts with engineering contractors for the management, civil and plant engineering design all of which are expected to be placed in January 2020.
“This agreement represents the completion of the preliminary engineering stage and I am most encouraged that the PHE team have achieved a major uplift in the performance of the DMG process, including almost doubling the hydrogen output to two tonnes, significantly enhancing our partners commercial drivers,” said David Ryan, CEO of PowerHouse Energy.
“The commitment demonstrates significant commercial confidence from Peel L&P Environmental to the immediate and long-term deployment of the process in the UK.”
Peel have also announced a strategy to develop “Plastic Parks” which will bring together potential counterparties for waste, power and hydrogen with a nett negative carbon dioxide contribution for each site.
“This further agreement reflects the confidence we have in the DMG Technology which will enable us to tackle the plastic challenge head on with an integrated approach to recycling and energy recovery,” said Myles Kitcher, Managing Director of Peel L&P Environmental.
“DMG allows us to eliminate landfill from our site, by regeneration of wasted plastic into power and hydrogen.”
“We are excited to be implementing our strategy in partnership with PowerHouse Energy and for Protos to be the first application of their ground-breaking technology to improve the waste management process and the environment in the UK.”
